Bioequivalence of Sandoz methylphenidate osmotic-controlled release tablet with Concerta® (Janssen-Cilag)

The aim was to assess the bioequivalence of Sandoz methylphenidate osmotic-controlled release (OCR) tablets (Sandoz [Methylphenidate[ MPH OCR) with Concerta®, a methylphenidate formulation indicated for the treatment of attention deficit/hyperactivity disorder (ADHD). Four open-label, randomized, si...

Descripción completa

Detalles Bibliográficos
Autores principales: Schapperer, Elisabeth, Daumann, Heike, Lamouche, Stéphane, Thyroff-Friesinger, Ursula, Viel, François, Weitschies, Werner
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317218/
https://www.ncbi.nlm.nih.gov/pubmed/25692005
http://dx.doi.org/10.1002/prp2.72

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317218/
https://www.ncbi.nlm.nih.gov/pubmed/25692005
http://dx.doi.org/10.1002/prp2.72

Ejemplares similares